See more : Khoon Group Limited (0924.HK) Income Statement Analysis – Financial Results
Complete financial analysis of EVe Mobility Acquisition Corp (EVE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EVe Mobility Acquisition Corp, a leading company in the Shell Companies industry within the Financial Services sector.
- Cardlytics, Inc. (CDLX) Income Statement Analysis – Financial Results
- PREMIER CAPITAL SERVICES LTD. (PREMCAP.BO) Income Statement Analysis – Financial Results
- Malee Group Public Company Limited (MALEE.BK) Income Statement Analysis – Financial Results
- Touchstone Exploration Inc. (TXP.TO) Income Statement Analysis – Financial Results
- NervGen Pharma Corp. (NGENF) Income Statement Analysis – Financial Results
EVe Mobility Acquisition Corp (EVE)
About EVe Mobility Acquisition Corp
EVe Mobility Acquisition Corp. focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Metric | 2022 | 2021 |
---|---|---|
Revenue | 0.00 | 0.00 |
Cost of Revenue | 1.05M | 0.00 |
Gross Profit | -1.05M | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 |
SG&A | 1.05M | 397.45K |
Other Expenses | 0.00 | 0.00 |
Operating Expenses | 1.05M | 397.45K |
Cost & Expenses | 1.05M | 397.45K |
Interest Income | 3.68M | 0.00 |
Interest Expense | 0.00 | 0.00 |
Depreciation & Amortization | 3.68M | 236.56K |
EBITDA | 2.63M | -397.45K |
EBITDA Ratio | 0.00% | 0.00% |
Operating Income | -1.05M | -397.45K |
Operating Income Ratio | 0.00% | 0.00% |
Total Other Income/Expenses | 3.68M | 608.00 |
Income Before Tax | 2.63M | -396.84K |
Income Before Tax Ratio | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -236.56K |
Net Income | 2.63M | -396.84K |
Net Income Ratio | 0.00% | 0.00% |
EPS | 0.08 | -0.01 |
EPS Diluted | 0.08 | -0.01 |
Weighted Avg Shares Out | 34.47M | 34.57M |
Weighted Avg Shares Out (Dil) | 34.47M | 34.57M |
Evolva to Acquire Allylix
Evolva & Cargill Announce Publication Of Stevia Reb M Patent Application
Evolva Starts Commercial Resveratrol Production
Evolva Successfully Places New Shares
Evolva reports preliminary, unaudited financial results for 2013 and announces launch of share placement
Evolva Announces Collaboration with L’Oréal
Evolva to Launch a Level-1 ADR Programme with BNY Mellon
Cargill und Evolva treten mit den durch Fermentation hergestellten Steviolglykosiden vorzeitig in die Pilotphase ein
Cargill and Evolva move into pilot scale ahead of schedule for fermentation-based steviol glycosides
Evolva And Cargill In Deal To Co-develop Steviol Glycosides
Source: https://incomestatements.info
Category: Stock Reports